30 C
Vientiane
Monday, July 21, 2025
spot_img
Home Blog Page 145

EnGenius Showcases Smarter AI and Cloud Networking Solutions at Interop Tokyo 2025

Cloud-Managed Wi-Fi 7 and AI Surveillance Solutions That Drive Innovation in Education, Hospitality, and Healthcare

TOKYO, June 2, 2025 /PRNewswire/ — EnGenius Networks Japan, the Japanese subsidiary of global cloud networking leader EnGenius Technologies, will exhibit its latest cloud-managed Wi-Fi 7 and AI surveillance solutions at Interop Tokyo 2025, taking place from June 11 to 13 at Makuhari Messe. Designed to drive digital transformation across education, hospitality, and healthcare sectors in Japan, these innovations deliver secure, high-performance, and easy-to-manage networking environments through cloud and AI integration.

EnGenius Interop booth mockup
EnGenius Interop booth mockup

Highlight Solutions to Show

As part of its comprehensive cloud-managed network ecosystem, EnGenius will introduce its latest Wi-Fi 7 solutions,  featuring ultra-fast performance up to 19 Gbps with 6 GHz band support, multi-link operation (MLO), and 4K QAM, and the sleek in-wall access point to deliver a space-saving, high-performance solution for high-density residential environments such as multiple dwelling units.

EnGenius will also present its contextual AI surveillance solution, which integrates edge computing and cloud-based AI to deliver real-time detection of people, objects, colors, and behaviors, such as walking, stopping, sitting, and picking up items. This technology enhances safety, efficiency, and user experience across a wide range of industries, including elder care, healthcare, retail, agriculture, and manufacturing.

“Our AI cameras are more than surveillance devices; instead, they are the core driver of operational efficiency and new value creation,” said Seiichiro Sato, General Manager of EnGenius Networks Japan. “From retail stores and care facilities to agriculture, fisheries, and manufacturing, our contextual AI recognition delivers real-time insights into the flow of people and objects. This enables businesses to improve productivity, streamline operations, enhance customer satisfaction, and ensure safety and stability across diverse industries.”

A key highlight of this year’s exhibition is EnGenius’s collaboration with NEC Networks & System Integration Corporation, the system integration arm of the NEC Group. By integrating Cloudbrink access, provided by NESIC, into the EnGenius Gateway series, this zero-trust networking solution offers secure, scalable, and high-performance connectivity tailored for Japanese enterprises and GIGA school initiatives.

Key Technologies

  • Advanced Wi-Fi 7 Connectivity
    Delivers next-generation wireless performance with up to 19 Gbps throughput, 6 GHz band support, and multi-link operation (MLO) for seamless, high-speed networking.
  • Contextual AI Recognition Uses large-scale multimodal modeling (LMM) techniques to detect complex scenarios, including suspicious behavior, potential security threats, and public safety events.
  • Natural Language Search of Surveillance
    Enables intuitive, multilingual queries, dramatically reducing search times for specific events in video footage.
  • AI-Network Video System (AI-NVS)
    A cloud-based solution that adds advanced AI analytics to existing ONVIF-compatible cameras and provides RAID-supported enterprise storage for secure, scalable video management.
  • Zero-Trust Network Access
    EnGenius Gateways integrate Cloudbrink services to establish secure, encrypted connections between edge devices, enterprise resources, and public cloud applications, enhancing both the security and performance of remote access.

Event Details

  • Event: Interop Tokyo 2025
  • Date: June 11–13, 2025, 10:00~18:00
  • Location: Makuhari Messe, Booth #5U24
  • Demo Reservation: Attendees who book a demo will receive a limited edition EnGenius Fisherman’s Net Bag. Book here

About EnGenius

EnGenius Technologies is a global leader in cloud-driven networking solutions, with over 25 years of expertise in developing and delivering innovative, user-friendly hardware and software. The company’s secure, cloud-managed ecosystem—including wireless access points, network switches, VPN routers, AI cameras, AI-powered network video systems, and power distribution units—empowers businesses across industries such as enterprise, education, healthcare, retail, and logistics to build high-performance, reliable, and scalable network infrastructures.

For more information, please visit the EnGenius website:  https://www..engeniustech.com/jp/interop-tokyo-2025

Medidata Debuts Protocol Optimization at ASCO, Leveraging AI to Transform the Study Experience

New solution improves protocol design, reduces patient- and site-burden, accelerates recruitment, and delivers increased efficiencies for clinical trials 

SINGAPORE, June 2, 2025 /PRNewswire/ — Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced the launch of Medidata Protocol Optimization, part of the Medidata Study Experience which is available on the Medidata Platform. Medidata is showcasing this novel solution at the American Society of Clinical Oncology (ASCO) 2025 conference, which will be held from May 30–June 3, 2025 in Chicago.

Medidata Protocol Optimization, a flagship component of the unified Study Experience, transforms trial design and execution by leveraging AI-driven predictive modeling, digital protocols, and industry-leading aggregated data to simulate trial performance. This solution has the ability to predict the impact on patient burden, site performance, and costs, well in advance of the First Patient In (FPI) resulting in research teams gaining critical foresight into the potential challenges. This approach significantly decreases costly amendments and enrollment delays, leading to smoother and lower cost trials.

“Oncology trials are some of the most intricate and demanding in clinical research, often leading to more changes during the study than any other therapeutic area,” said Dan Braga, senior vice president, Study Experience, Medidata. “Because of this complexity, we wanted to introduce Protocol Optimization at ASCO to give researchers a deeper look into how balancing scientific intention and practical execution can bring treatments to the market more effectively.”

To learn more about Protocol Optimization, please visit here.

About Medidata

Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. Celebrating 25 years of ground-breaking technological innovation across more than 36,000 trials and 11 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and one of the largest clinical trial data sets in the industry. More than 1 million registered users across approximately 2,300 customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. A Dassault Systèmes brand (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC. Discover more at www.medidata.com and follow us @Medidata.

About Dassault Systèmes

Dassault Systèmes is a catalyst for human progress. Since 1981, the company has pioneered virtual worlds to improve real life for consumers, patients and citizens.  With Dassault Systèmes’ 3DEXPERIENCE platform, 370,000 customers of all sizes, in all industries, can collaborate, imagine and create sustainable innovations that drive meaningful impact.  For more information, visit: www.3ds.com.

ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies

PETACH TIKVA, Israel, June 2, 2025 /PRNewswire/ — ASP Isotopes Inc. (NASDAQ: ASPI) and Isotopia Molecular Imaging Ltd. have entered into a strategic agreement to secure the supply of Gadolinium-160 (Gd-160), a critical precursor isotope for producing Terbium-161 (Tb-161), an emerging medical isotope with significant potential in targeted radiotherapeutics.  
This partnership addresses longstanding supply challenges for Gd-160, enabling Isotopia to advance Tb-161-based therapies for prostate cancer, neuroendocrine tumors, and other malignancies. 

Under the agreement, ASP Isotopes will leverage its proprietary Quantum Enrichment technology to provide Isotopia with enriched Gd-160, a stable isotope essential for manufacturing Tb-161.  
The collaboration combines ASP Isotopes’ expertise in large-scale isotope enrichment—previously demonstrated through its production of Ytterbium-176 (Yb-176)—with Isotopia’s proven capabilities in commercial-scale medical isotope production. Isotopia has consistently manufactured Lutetium-177 (Lu-177) and maintained weekly Tb-161 production for its clinical trials over the past two years. 

Paul Mann, CEO  of ASP Isotopes, emphasized the agreement’s significance: “By supplying Gd-160, we are eliminating a major bottleneck in the development of Tb-161 therapies. Our investment in enrichment technology positions us to support the radiopharmaceutical industry’s growing demand for stable isotopes. This partnership accelerates the path to clinical adoption of Tb-161, which could redefine cancer treatment paradigms.” 

Dr. Eli Shalom, CEO of Isotopia, highlighted Tb-161’s therapeutic advantages: “Tb-161’s dual mechanism of action, including Auger electron emissions, enables precise targeting of micro-metastases while minimizing damage to healthy tissues. This partnership ensures a reliable Gd-160 supply chain, allowing us to scale production and advance our Tb-161-labeled drug candidates toward commercialization. We produce in our site in Israel and shortly the production will start in our second site in Indianapolis in the US.” 

Tb-161’s Auger electrons induce double-strand DNA breaks in cancer cells, offering potential advantages over Lu-177 and alpha-emitting isotopes. This precision aligns with the oncology field’s shift toward targeted radiotherapeutics, which improve efficacy and reduce side effects. The agreement comes as global interest in radiopharmaceuticals surges, driven by their ability to deliver localized radiation therapy via tumor-seeking molecules. 

About ASP Isotopes Inc. 
ASP Isotopes Inc. specializes in advanced isotope separation technologies, including its proprietary Aerodynamic Separation Process and Quantum Enrichment, which produce stable isotopes without radioactive waste. The company’s initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. The Company has isotope enrichment facilities in Pretoria, South Africa. For more information, please visit www.aspisotopes.com.

About Isotopia Molecular Imaging Ltd. 
Isotopia is a global leader in medical isotope production, with facilities in Israel, Europe, and the U.S. Its integrated platform includes cyclotrons, Lu-177 and Tb-161 production sites, and sterile manufacturing capabilities. The company collaborates with researchers and clinicians to develop novel radiopharmaceuticals for diagnostics and targeted therapy. 

This partnership positions both companies at the forefront of the radiopharmaceutical revolution, with the potential to expand treatment options for cancer patients worldwide. 

Contact: eshalom@isotopia-global.com 

Medidata Debuts Protocol Optimization at ASCO, Leveraging AI to Transform the Study Experience

New solution improves protocol design, reduces patient- and site-burden, accelerates recruitment, and delivers increased efficiencies for clinical trials

SINGAPORE, June 2, 2025 /PRNewswire/ — Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced the launch of Medidata Protocol Optimization, part of the Medidata Study Experience which is available on the Medidata Platform. Medidata is showcasing this novel solution at the American Society of Clinical Oncology (ASCO) 2025 conference, which will be held from May 30–June 3, 2025 in Chicago.

Medidata Protocol Optimization, a flagship component of the unified Study Experience, transforms trial design and execution by leveraging AI-driven predictive modeling, digital protocols, and industry-leading aggregated data to simulate trial performance. This solution has the ability to predict the impact on patient burden, site performance, and costs, well in advance of the First Patient In (FPI) resulting in research teams gaining critical foresight into the potential challenges. This approach significantly decreases costly amendments and enrollment delays, leading to smoother and lower cost trials.

“Oncology trials are some of the most intricate and demanding in clinical research, often leading to more changes during the study than any other therapeutic area,” said Dan Braga, senior vice president, Study Experience, Medidata. “Because of this complexity, we wanted to introduce Protocol Optimization at ASCO to give researchers a deeper look into how balancing scientific intention and practical execution can bring treatments to the market more effectively.”

To learn more about Protocol Optimization, please visit here.

About Medidata

Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. Celebrating 25 years of ground-breaking technological innovation across more than 36,000 trials and 11 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and one of the largest clinical trial data sets in the industry. More than 1 million registered users across approximately 2,300 customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. A Dassault Systèmes brand (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC. Discover more at www.medidata.com and follow us @Medidata.

About Dassault Systèmes

Dassault Systèmes is a catalyst for human progress. Since 1981, the company has pioneered virtual worlds to improve real life for consumers, patients and citizens.  With Dassault Systèmes’ 3DEXPERIENCE platform, 370,000 customers of all sizes, in all industries, can collaborate, imagine and create sustainable innovations that drive meaningful impact.  For more information, visit: www.3ds.com.

Logo – https://laotiantimes.com/wp-content/uploads/2025/06/medidata_logo-1.jpg

TuniTuni Opens New Storytelling Kids’ Gym in Shek Mun, Hong Kong

HONG KONG, June 2, 2025 /PRNewswire/ — TuniTuni, the beloved Korean kids’ gym brand, is thrilled to announce the opening of its second Hong Kong center in Shek Mun on 1st June 2025. Located at Unit N, P. 19/F Kings Wing Plaza 2, No 1 On Kwan Street, Shatin, this new facility follows the phenomenal success of its first location, TuniTuni Lohas, which launched in 2024. Due to overwhelming demand, we’re expanding TuniTuni centers to serve more families, bringing our unique “storytelling gym” experience to even more children across the city.

A child enjoys a storytelling gym session at TuniTuni’s new Shek Mun center in Hong Kong.
A child enjoys a storytelling gym session at TuniTuni’s new Shek Mun center in Hong Kong.

TuniTuni Lohas made waves in its debut year. Since its opening, over 2,500 students have experienced the TuniTuni program. The center has since been in great demand, with a long waiting list of eager families. Parents have consistently praised the excellent program and the sheer joy it brings their children, highlighting how TuniTuni’s innovative approach fosters a love for movement through “learn and jiggle, play and giggle.”

Building on this success, the new Shek Mun center is already off to a remarkable start, with more than 300 trial students registered even before the official opening. This overwhelming response underscores TuniTuni’s reputation for delivering engaging, fun, and educational experiences that captivate young minds and bodies.

“Our mission is to create a space where kids can explore, grow, and have fun through dynamic storytelling and active play,” said Mr. Austin Oh, CEO at TuniTuni Hong Kong. “The incredible feedback from parents and the enthusiasm of our young members inspire us to bring TuniTuni’s magic to more communities.”

The Shek Mun center will feature TuniTuni programs, designed to spark creativity and promote physical development in a joyful environment. Families can look forward to the same high-quality experience that has made TuniTuni a household name among Hong Kong parents.

For more information about TuniTuni Shek Mun, including class schedules and registration details, visit www.tunituniglobal.com or contact  WhatsApp [852-5645 5370].

Join us at TuniTuni, where every class is a story, and every movement is a moment of delight!

About Daekyo Hong Kong

Daekyo Hong Kong is the Hong Kong subsidiary of Daekyo, a leading global education company founded in 1976. Operating in 19 countries worldwide, Daekyo is dedicated to providing personalized education tailored to each child’s level. Daekyo Hong Kong has proudly operated the Eye Level brand, focusing on English and Mathematics education, since 1997. Expanding its offerings, the company also launched and has been successfully operating the TuniTuni early childhood physical education brand since June 2024.

Creative Primary School and Creative Primary School’s Kindergarten Celebrate 40th Anniversary with Successful Open Day


HONG KONG SAR – Media OutReach Newswire – 2 June 2025 – On 24 May 2025, Creative Primary School (CPS) and Creative Primary School’s Kindergarten (CPSKG) held a grand open day to celebrate their 40th anniversary, welcoming guests, parents, alumni, and community members. Nestled in the prestigious educational hub of Oxford Road, Kowloon Tong, Hong Kong, China, these two institutions have, for four decades, served as distinguished private schools, delivering exceptional education and nurturing generations of outstanding students.

Established in 1985, CPS and CPSKG have championed holistic education, aligning with Hong Kong's 2000 education reforms emphasizing critical thinking, character, and lifelong learning.
Established in 1985, CPS and CPSKG have championed holistic education, aligning with Hong Kong’s 2000 education reforms emphasizing critical thinking, character, and lifelong learning.

Student-Led Exhibitions and Performances
The day featured the IB PYP Units of Inquiry Exhibition, student-led research presentations, workshops, and performances, reflecting the school’s commitment to holistic education. Parents explored the campus guided by students, while alumni reconnected with teachers. Special guests from the International Alliance for Invitational Education (IAIE) attended, highlighting the school’s “Care, Respect, and Trust” culture.

CPSKG’s “Sky of Growth” exhibition showcased child-led learning across subjects like English, Chinese, science, robotics, and art, embodying the philosophy of “Inspiring curiosity, nurturing explorers.” Teachers guided students in constructing knowledge through research, fostering critical thinking and lifelong learning. Parents admired the children’s creativity, witnessing the student-centered curriculum in action.

An alumnus shared: “Returning to my alma mater let me see the school’s ongoing innovation.”

Forty Years of Excellence
Established in 1985, CPS and CPSKG have championed holistic education, aligning with Hong Kong’s 2000 education reforms emphasizing critical thinking, character, and lifelong learning. With the later addition of Creative Secondary School (CSS), the institution now offers a seamless 3–18 education, blending Eastern and Western pedagogy.

Global Recognition and Future Vision
As an IB World School, the institution emphasizes inquiry-based learning, with trilingual (English, Chinese, Putonghua) foundations in early years and English-medium secondary education. Its “Inviting School Award” from IAIE underscores its nurturing environment.

Mr. Victor Fong, Open Day Committee Chairman and School Supervisor, noted: “In an era of AI and rapid change, we remain committed to cultivating adaptable, compassionate leaders.” He thanked faculty and parents for their support.

The open day celebrated past achievements while marking a new chapter. The school invites the community to join its journey—inspiring future generations of learners.

Factual Highlights of the Creative Schools Continuum
Three Schools ‧ One Philosophy ‧ One Continuum

  • The motto of Creative Schools Continuum is “Nurture Future Minds * Build Boundless Capacity”, highlighting the continuum’s foresights and insights of quality education and our commitments to our students and parents.
  • Creative Primary School and Creative Secondary School are award-winning “Inviting Schools”. The award recognizes the schools’ commitments to providing an exceptionally caring, trusting, respectful and positive learning environment for its students and staff.
  • As International Baccalaureate (IB) World Schools, Creative Primary and Creative Secondary Schools offer the IB Primary Years Programme (IB PYP), IB Middle Years Programme (IB MYP) respectively.
  • Creative Secondary School also offers the Hong Kong Diploma of Secondary School Examination (HKDSE) course in parallel with the IB Diploma Programme (IBDP) as pathways to university entrances.

Hashtag: #CSS #CPS #CPSKG #CreativeSchoolsContinuum

The issuer is solely responsible for the content of this announcement.

Unlocking Trillions: How Data Fuels China- Thailand Business Boom

SHENZHEN, China, June 2, 2025 /PRNewswire/ — This is a news report from Shenzhen Media Group:

“When there’s a big volume of products from China, it also helps the Thai economy because people can buy things cheaper than produced in Thailand.” Recently, Thai Foreign Minister Maris Sangiampongsa responded to a question by Bloomberg TV’s  interview on concerns about whether an influx of Chinese goods imports into Thailand. Maris Sangiampongsa said, “What I am trying to say is, we have to work and to find, to be able to see the advantage of working together with Asean to fulfill the global supply chain.”

2025 marks the 50th anniversary of the establishment of diplomatic relations between China and Thailand, as well as the “the Golden Jubilee of China-Thailand Friendship.” Over the past five decades, the scale and scope of economic and trade cooperation between the two countries has continuously expanded and deepened, with digital technology emerging as a key area of collaboration.

As the global live-streaming shopping craze sweeps the world, typified by the catchphrase “3, 2, 1, link it up!”, traditional Thai supermarkets are also undergoing transformation. To keep pace with this shift, Thai supermarket giant BigC is partnering with Shenzhen-based internet companies Xingyun Group to pioneer innovative digital marketing strategies.

The team of Shenzhen TV’s program “Telling China’s Story” visited a Thai supermarket to explore how businesses leverage big data to precisely capture consumer preferences, turning Thai specialties like mango chips and durian chips into Internet latest superstar.

With the support of digital marketing, Thailand’s retail sector has experienced a significant boost in sales and expanded access to emerging markets, particularly China. This not only helps cushion the impact of U.S. tariffs, but also opens new avenues for traditional Thai supermarkets to address global trade challenges.

Have you ever wondered what it’s like to sell goods through live-streaming in Thailand? As new trade channels are being opened, what ingenious strategies are Chinese and Thai practitioners bringing to the table? Let’s find out on Telling China’s Story short video series Make Money Together “Unlocking Trillions: How Data Fuels the China-Thailand Business Boom”!

Dilon Technologies Partners with Australian Allografts as Exclusive Distributor for Navigator 2.0™ Gamma Localization System in Australia

NEWPORT NEWS, Va., June 2, 2025 /PRNewswire/ — Dilon Technologies is pleased to announce the partnership of Australian Allografts as the exclusive distributor of the Navigator 2.0™ Lymphatic Mapping System in Australia, effective immediately.

This strategic collaboration reflects Dilon Technologies’ ongoing commitment to delivering exceptional patient care through advanced medical technology. By partnering with Australian Allografts and their specialized support team, Dilon is enhancing access to the Navigator 2.0 system and reinforcing their ability to provide localized, responsive service throughout the region.

“Dilon Technologies remains steadfast in its mission to improve patient outcomes by equipping healthcare providers with precise, reliable, and user-friendly technology. The Navigator 2.0 Gamma Localization System is a critical component in breast surgery, and ensuring its continued availability is central to our dedication to clinicians and the patients they serve,” stated George Makhoul, CEO of Dilon Technologies.

In addition to the Navigator 2.0 system, Australian Allografts will also support the full portfolio of Dilon products, upholding the high standards of quality, performance, and support that healthcare providers and their patients rely on.

Logo – https://laotiantimes.com/wp-content/uploads/2025/06/dilon_technologies_logo.jpg